KalVista Pharmaceuticals (KALV) Return on Sales (2014 - 2025)

KalVista Pharmaceuticals (KALV) reported Return on Sales of 0.01% for Q3 2025, up 7.0% on a YoY basis from 0.01% in Q3 2024, and up 74.67% sequentially from 0.05% in Q2 2025.

KalVista Pharmaceuticals (KALV) Return on Sales (2014 - 2025) Analysis & Trends

KalVista Pharmaceuticals (KALV) has 9 years of Return on Sales data on file, last reported at 0.01% in Q3 2025.

  • For the quarter ending Q3 2025, Return on Sales rose 7.0% year-over-year to 0.01%; the trailing twelve-month figure through Jul 2025 stood at 0.03% (up 6.0% YoY), and the FY2025 full-year result was 0.17%, down 16.0% from the prior year.
  • Return on Sales rose to 0.01% in Q3 2025, from 0.05% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.01% in Q3 2025 to a low of 0.08% in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.00%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 0.00%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.00%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 0.00%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 KalVista Pharmaceuticals 1.36 Bn 1.36 Bn 49.41 Mn -0.01%

Historic Data

Download Data
DateValue
Jul 31, 2025 -0.01%
Apr 30, 2025 -0.05%
Jul 31, 2024 -0.08%
Apr 30, 2020 -0.02%
Jan 31, 2020 -0.09%
Oct 31, 2019 -0.03%
Jul 31, 2019 -0.03%
Apr 30, 2019 -0.04%
Jan 31, 2019 -0.02%
Oct 31, 2018 -0.01%
Jul 31, 2018 -0.02%
Apr 30, 2018 -0.01%
Jan 31, 2018 -0.02%
Oct 31, 2017 -0.05%
Jul 31, 2017 -0.62%
Apr 30, 2017 -0.45%
Jan 31, 2017 -0.33%
Oct 31, 2016 -0.20%
Jul 31, 2016 -0.05%
Mar 31, 2016 -10.23%